Diffusion tensor imaging in the SPRINT-MS clinical trial: Advancing trial methodology
{{output}}
Background: SPRINT-MS was a placebo-controlled phase 2 trial of ibudilast in secondary and primary progressive multiple sclerosis. The trial included multimodal imaging to assess brain tissue integrity. This contribution focuses ... ...
